The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis
about
Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodelingThe Pathogenesis of Resection-Associated Intestinal AdaptationInfluences of excluded volume of molecules on signaling processes on the biomembranePRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells.Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFRSmall molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivoActivation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility.Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular SystemPodoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregationPlasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic miceYAC tripeptide of epidermal growth factor promotes the proliferation of HaCaT keratinocytes through activation of EGFR.The Effects of Eucheuma cottonii on Signaling Pathway Inducing Mucin Synthesis in Rat Lungs Chronically Exposed to Particulate Matter 10 (PM10) Coal DustADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1).A disintegrin and metalloprotease 17 mediates neointimal hyperplasia in vasculature.Role of PKCδ in Enhanced Expression of Gqα/PLCβ1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats.Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis.Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis.Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cellsAugmented EGF receptor tyrosine kinase activity impairs vascular function by NADPH oxidase-dependent mechanism in type 2 diabetic mouse3,4-dihydroxyphenyl acetic acid and (+)-epoxydon isolated from marine algae-derived microorganisms induce down regulation of epidermal growth factor activated mitogenic signaling cascade in Hela cells.Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.The epidermal growth factor receptor and its ligands in cardiovascular disease.Angiogenesis in the atherosclerotic plaque.Signal molecule-mediated hepatic cell communication during liver regeneration.MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.Growth factors: possible roles for clinical management of the short bowel syndrome.Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress.Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice.A mechanism for sickness sleep: lessons from invertebrates.EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation.Evidence for the Effects of Xanthohumol in Disrupting Angiogenic, but not Stable Vessels.Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion.Synergistic induction of mitogen-activated protein kinase phosphatase-1 by thrombin and epidermal growth factor requires vascular endothelial growth factor receptor-2.The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.HB-EGF affects astrocyte morphology, proliferation, differentiation, and the expression of intermediate filament proteins.
P2860
Q24646402-0F5F9D01-7719-4F62-BE5F-8768293C7406Q28076127-BFAF1A00-D882-44DF-9755-05780885B9D6Q28487592-4D5329AA-E170-4DBE-B5E3-FC4A0AA27594Q28594760-91196C6A-8B37-44A5-8F79-618029427627Q30415389-19BFFC05-F21D-4ADE-987E-1D9F63081B5EQ33417863-E2D1C05A-2780-4521-9C9B-A4E244BC6C17Q33563932-656B21AA-4682-4E44-BA2D-6E3B5A2817E7Q33814199-F2AFF2C9-670D-4D53-996D-9E09C171F6C3Q33826371-B038113D-C068-407D-892C-9FFDCDA5E442Q34251521-5DBA2AC5-33B4-4C42-8FB9-A3B88B41F3B0Q34505220-8B2190D3-FC43-4CF4-8FA6-C7BDC5AEA286Q34667258-D8BE9935-80D1-4DEF-BC39-10B65D2DB7F8Q35042322-6A3A43B6-2EDE-4AB7-80BE-A442FFDDD9FFQ35077020-FFBB2605-EF2E-47E6-9D0D-272A34F01107Q35848839-EFB52C1E-9503-4AD5-80D7-51B3117162FFQ36068101-456EE57B-E8E3-499F-8C70-4FD951AA8A1CQ36089848-100B8E9C-AA72-405D-865C-30575A2E39EDQ36319377-F8D60FB6-0F6F-4D64-9BA2-946D46C1FE5FQ36352710-78BC1788-C41C-44D1-B4A9-C54F3794AFB2Q36867045-E3F86E2E-6560-41C6-970C-90ADC3E70BB3Q36905911-5F99BDCC-30F4-4046-90AB-0DF57E8939BAQ37139302-33679CC0-CA2D-4061-B0EE-ABB086DF8BF9Q37218194-705A7B9C-411B-4BA5-B173-B1AADB899CB4Q37291330-B735607B-C830-445D-98FF-B1638DC21402Q37645436-8E9D613D-FA76-4084-AEBE-6FA8ACAE62CDQ37649635-22399920-92AA-458F-9C83-1477E0BBF977Q37664093-631BCED2-021A-4D53-AC43-4A105524FBDAQ37685500-9515D3D1-F81C-4F2B-B655-51C192919504Q37736555-C62E6417-CEEE-44DB-87A0-EE7687196CB7Q38287552-56805CF3-8034-4D3A-A8AD-B2C1E1A97015Q38705556-A73E5235-EA0B-4F78-B676-4BFF21EE1A87Q38777485-42DB281D-F593-42D4-87CA-533F501BEFD5Q39060211-7C706233-D533-4B72-B080-B77B61CFA399Q39208743-CBADE1EF-49D2-494B-BEC8-7EAB98425FCFQ39496836-980E3897-B3FA-40AE-B4B5-D8B7756A4C4CQ39525746-390636BE-F952-44F4-A86D-C94AFFC4D7F6Q41630808-8D7DE8B2-CF8F-4BAA-B7D3-8397674F1FBBQ42409102-5440462E-0F9C-4A3B-979F-011338CC5D04Q42876722-E74350B7-03DE-4D67-99D0-692F4336A52FQ44598034-B00BFC34-3120-44F4-92C9-7FBBDC6AE824
P2860
The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The epidermal growth factor re ...... putative role in atherogenesis
@ast
The epidermal growth factor re ...... putative role in atherogenesis
@en
The epidermal growth factor re ...... putative role in atherogenesis
@en-gb
The epidermal growth factor re ...... putative role in atherogenesis
@nl
type
label
The epidermal growth factor re ...... putative role in atherogenesis
@ast
The epidermal growth factor re ...... putative role in atherogenesis
@en
The epidermal growth factor re ...... putative role in atherogenesis
@en-gb
The epidermal growth factor re ...... putative role in atherogenesis
@nl
prefLabel
The epidermal growth factor re ...... putative role in atherogenesis
@ast
The epidermal growth factor re ...... putative role in atherogenesis
@en
The epidermal growth factor re ...... putative role in atherogenesis
@en-gb
The epidermal growth factor re ...... putative role in atherogenesis
@nl
P2093
P3181
P1433
P1476
The epidermal growth factor re ...... putative role in atherogenesis
@en
P2093
Alys C Dreux
David J Lamb
Gordon A A Ferns
P3181
P356
10.1016/J.ATHEROSCLEROSIS.2005.06.038
P407
P577
2005-08-01T00:00:00Z